Ask AI

Emerging Evidence in Obesity Care: Translating the Data Into Primary Care Decisions and What to Expect From the 2026 ObesityWeek

Conference Coverage Clinical Thought
Conference Coverage Clinical Thought Start Activity
This activity is available for 0.25 CME/CE credit(s).

Released: November 04, 2026

Expiration: November 03, 2027

See Activity Collection

The latest obesity evidence offers new and updated interpretations about the efficacy and safety of established and emerging obesity management medications. Learn how these data impact individualized, long-term obesity care in the primary care setting, including the importance of addressing patients’ comorbidities and complications, assessing treatment response beyond weight loss alone, planning for maintenance at the start, and preserving nutrition and function through shared decision-making.

2026 obesity evidence in primary care

Pre Assessment

Assess your current knowledge and clinical approach before beginning your ClinicalThought.
1.

How many people with obesity do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

A 62-year-old woman with obesity and hypertension has lost 12% of her baseline body weight during 8 months of incretin-based therapy. Her blood pressure and knee discomfort have improved, and her weight has been stable for 6 weeks. She reports persistent nausea, reduced food intake, and difficulty completing her usual walks. She asks to increase her dose after reading about a trial reporting an average weight reduction of -25%. Her main goal is to walk comfortably with her grandchildren.

Which management approach is most appropriate?